Podcast appearances and mentions of daisy robinton

Dr. Daisy Robinton, co-founder and CEO of Oviva Therapeutics, discusses the company's innovative approach to improving women's healthspan by targeting the biology of ovarian aging. Motivated by her personal experiences and the realization that female physiology is underserved by research and medicine, Daisy outlines how menopause is a key inflection point in the acceleration of aging in women. She explains the central role of anti-Mullerian hormone (AMH) in regulating ovarian function and fertility. Oviva's lead program, a recombinant enhanced AMH protein, aims to improve IVF outcomes by synchronizing follicle growth. Excitingly, this approach could also preserve ovarian reserve to delay menopause onset, thereby extending female healthspan.Key Topics Covered:Pivoting from developmental biology to found a women's health startupOvaries as central regulators of female healthspan beyond reproductionAMH as a brake on follicle activation and loss of ovarian reserveUsing enhanced AMH to improve egg yield in poor-responding IVF patientsPotential of AMH-based therapy to delay menopause and slow agingMenopause as the single greatest known accelerator of agingEconomic and societal impact of extending female healthspanDistinguishing reproductive longevity from overall women's healthViewing fertility as a marker of overall health and wellbeing

Today, I'm joined by Dr. Daisy Robinton, co-founder & CEO of Oviva Therapeutics. Daisy is a Harvard-trained molecular biologist on a mission to extend female healthspan. Targeting ovarian function as a lever for longevity, Oviva hopes to make menopause optional. In this episode, we discuss how Oviva Therapeutics plans to deliver additional years of vibrant living to women. Plus, we talk about the intersection of biology and longevity. We also cover: • The future of women's health • How lifestyle interventions impact aging • Oviva's process for developing novel therapeutics Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscribe Follow us on LinkedIn → linkedin.com/company/fittinsider Oviva Therapeutics Website: https://www.ovivatx.com/ Daisy's LinkedIn: https://www.linkedin.com/in/daisy-robinton-phd-97785b35/ Daisy's IG: https://www.instagram.com/daisy_robinton/?hl=en Daisy's Email: Daisy@ovivatx.com Daisy Speaking at SXSW: https://www.shemedia.com/sxsw-2024/speakers Daisy Speaking at Live Long Summit: https://www.livelongsummit.com/ -   The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities.  Fitt Talent: https://talent.fitt.co/ Consulting: https://consulting.fitt.co/ Investments: https://capital.fitt.co/ Chapters:  (00:00) Introduction (01:31) Oviva Therapeutic background (03:35) Understanding ovarian aging (07:09) Oviva's scientific research (10:08) Challenges and opportunities in women's health (11:34) Operations of a biotech company (16:00) Oviva's long-term goals  (19:35) The future of women's health and longevity (20:46) Preserving ovarian function (21:50) Therapeutic interventions and lifestyle changes for women's health (23:29) Timeline for the therapeutics to be released (26:01) Consumer education and regulatory changes (31:52) Efficacy and skepticism (35:24) Conclusion

We have undeniably come a long way when it comes to health. Yet, there is still so much that hasn't been explored about women's health. There is a noticeable gap in how women can learn about the different chapters of their lives. Dr. Daisy Robinton, the Co-founder and CEO of Oviva Therapeutics, is elevating conversations around women's health, helping them live longer, healthier lives. In this episode, she discusses hormones, ovaries, and our overall reproductive health and the current struggles in the space to tackle the unknowns and black boxes on them. Plus, Dr. Robinton shares the great things they are doing at Oviva to help women through ovarian physiology to live with longer vitality and better health.

What is up with the precocious nature of ovaries and how could a deeper understanding of this organ help women lead longer, more fun lives?The ovaries age two and a half times faster than any other organ in the body, yet we know nothing about why this happens. We will speak to Daisy about the work Oviva is doing to extend the health span of women by developing novel therapeutics that support and hopefully extend the life and function of the ovaries. If she's successful, it could give women the choice of experiencing menopause. With more context around why menopause happens to humans with ovaries and the culture that stigmatizes women's aging, we can reclaim choice and power in our own lives Dr Daisy Robinton is CEO of Oviva, a biotech company focused on Ovarian health and longevity which aims to address the historical gender bias in biomedical research and healthcare. She is a Molecular Biologist and completed a PhD from Harvard in 2016. In 2016 she was listed on the Forbes 30 under 30 for her scientific discoveries. She's also a TEDx speaker and fitness model. When she's not saving the world and being a badass women's Health Advocate, she's a Mama bear to wee baby Scarlett.

Welcoming a child into your family can be life changing, but for those struggling to get pregnant the process can be emotionally taxing and expensive. Reproductive science is quickly changing, as is society's approach to the issues around fertility. In this episode, we bring you a conversation from the WSJ Future of Everything Festival, where a handful of medical practitioners and reproductive entrepreneurs discussed the future of fertility with WSJ's Amy Dockser Marcus. Guests include: sociologist Rene Almeling, Stephen Krawetz, the Associate Director of the CS Mott Center for Human Growth and Development, Daisy Robinton, the CEO of Oviva Therapeutics and Angela Stepancic, the founder of Reproductive Village Cryobank. This conversation was recorded before the Supreme Court's decision overturning Roe v. Wade. Useful Links: See more videos from The WSJ Future of Everything Festival   GUYnecology: The Missing Science of Men's Reproductive Health  Krawetz Lab at the C.S. Mott Center for Human Growth and Development Oviva Therapeutics  Reproductive Village Cryobank  Learn more about your ad choices. Visit megaphone.fm/adchoices

BONUS EPISODES & FULL ACCESS TO VIDEO VERSIONS OF THE AUXORO PODCAST: https://auxoro.supercast.tech/ Dr. Daisy Robinton is the Co-Founder of Oviva Therapeutics, a molecular biologist, and a science storyteller.  DR. DAISY ROBINTON LINKS: Oviva Therapeutics: https://www.ovivatx.com/ Cambrian BioPharma: https://bit.ly/2UIlckr Twitter: https://twitter.com/DaisyRobinton  THE AUXORO PODCAST LINKS:Apple: https://apple.co/3B4fYju Spotify: https://spoti.fi/3zaS6sPOvercast: https://bit.ly/3rgw70DClips Playlist: https://bit.ly/3r9Qxsa Full Episodes Playlist: https://bit.ly/3r83in3 Website: https://www.auxoro.com/ AUXORO SOCIAL LINKS:Instagram: https://www.instagram.com/auxoroTwitter: https://twitter.com/AuxoromagFacebook: https://www.facebook.com/auxoromagNewsletter: https://www.auxoro.com/thesource If you enjoy the show, please consider leaving a short review on Apple Podcasts. It takes less than 60 seconds, helps us appear higher in searches so more people discover the show, and it boosts my ego;) Past Guests On The Auxoro Podcast Include: Aubrey de Grey, Andy Weir, Eben Britton, Eric Jorgenson, Isabelle Boemeke, Houston Arriaga, Jerzy Gregorek, Chris Cooper, Gryffin, Elsa Diaz, Dave Robinson, Meghan Daum, FINNEAS, Chloé Valdary, Coleman Hughes, Maziar Ghaderi, YONAS, Ryan Michler, Ryan Meyer, Gavin Chops, Bren Orton, Zuby, Jason Khalipa, Ed Latimore, Jess Glynne, Noah Kahan, Kid Super, Deryck Whibley, and many more.  Audio editing by dbsound: https://www.fiverr.com/dbsound

Dr. Daisy Robinton challenges the assumptions we hold about the world and about ourselves. Her work as a molecular biologist, writer, public speaker, and lifestyle and fitness model, all contribute to the unique lens with which she examines the intersection of science and culture. Robinton completed her PhD in Human Biology and Translational Medicine at Harvard University in 2016 and landed on the Forbes 30 Under 30 list in 2017 for her scientific discoveries. Her writing has been published in periodicals such as Nature, Developmental Cell, Vanity Fair and NEO.LIFE. Working with brands like Neutrogena, lululemon, Powerade and Reformation, Dr. Robinton has traveled all over the world for her work in marketing campaigns and in developing the next generation of consumer products informed by biotechnology. Her passion for the effective translation of science has fueled her years of teaching, speaking, and consulting on numerous projects in the US and abroad. She is currently working as a Scientist in Residence developing novel preclinical programs and therapeutic strategies targeting women's health, menopause, and human healthspan. Instagram: @daisy_robinton Twitter: @DaisyRobinton

Currently, the media contains a ton of information surrounding viruses, diseases, and vaccines. However, people may be wondering what exactly these terms mean, so today we are going to start with square one and work our way to the details. The goal is to better understand how COVID-19 is currently playing out, and how things may play out in the future.  Our guest for today is Dr. Daisy Robinton, who is a microbiologist who received a PhD in Human Biology and Translational Medicine from Harvard University in 2016. She also landed a spot on Forbes 30 under 30 in 2017 for her scientific discoveries. Daisy is also the co-founder of Weird and Wonderful, which is a production company aimed at bridging the knowledge gap in science by connecting creativity and entertainment to engage, educate, and inspire people from all walks of life.  Today we are going to discuss... What a virus is What some of the important differences between COVID-19 and the flu are What our guest's own experience with COVID-19 was like Some countries, their current actions, and how things are looking in those countries Learn more about our guest: Twitter: @DaisyRobinton Instagram: @Daisy_Robinton LinkedIn: Daisy Robinton

In this episode of the Red Shoes Living podcast, Lonnie Mayne and Dr. Daisy Robinton discuss what it takes to navigate and to truly bear witness to what we are all going through during these incredibly challenging times, and Dr. Robinton talks about the science of what is happening to the human psyche through these experiences. We learn how we as leaders need to stop and listen in order to be effective with our teams, and what will stay with us and what we will learn from these unprecedented, collective human experiences we are all sharing across the world.

Harvard trained molecular biologist, fitness model, and science communicator Dr. Daisy Robinton has answers to all your questions! Why does Physical touch feel so good? What can you do if you’re feeling lonely and isolated during this stay at home period? Why do we need more women in science and what’s it like to be a scientist who’s pretty for a living. Connect with Daisy:Instagram- https://www.instagram.com/daisy_robinton/?hl=enLinkedin - https://www.linkedin.com/in/daisy-robinton-phd-97785b35Facebook - https://www.facebook.com/DaisyRobintonPhD/ Show Sponsor  Let's Get Checked - Male Hormone Testhttp://trylgc.com/wildlovetrylgc.com/WILDLOVEUse code (WILDLOVE for 20% Off) Sweet Vibrations https://sweetvibes.toys/ Use the code "Wild Love" to get 15% off at checkout  Connect with Wednesday Martin:Website | http://wednesdaymartin.com/Instagram | https://www.instagram.com/wednesdaymartinphd/Twitter | https://twitter.com/WednesdayMartinFacebook | https://www.facebook.com/wednesdaymartinphd/YouTube | https://bit.ly/2zfvv1H Check out Wednesday Martin’s new book Untrue |http://wednesdaymartin.com/books/untrue/ Connect with Whitney Miller:Instagram | https://www.instagram.com/whitnlove/?hl=enFacebook | https://www.facebook.com/Miss2Jits/Twitter | https://twitter.com/whitnlove Subscribe on iTunes https://apple.co/2XKfS0bSpotify | https://spoti.fi/2JPxuhnStitcher | https://bit.ly/2xYNQz0  Google Play Music | bit.ly/30nJwWAIHeartRadio | https://ihr.fm/2NooEuw

We think a lot about the things we put into our bodies but there is a relatively new field coming into the spotlight as we learn more about the things that are already in, and on, our bodies.  That field is research into the human microbiome.  Our guest today tells us about some of the early and most recent developments, and how the data being gathered about the micro organisms living in our bodies can help to develop new treatments to existing conditions, and prevent developing others. Our guest is Azza Gadir, a scientist working on the Immunology of food allergies at Harvard University/Boston Childrens’ hospital. Her research is focused on the role of the Gut Microbiome in preventing and treating disease. In addition, she is currently serving as a scientific advisor for the startup, Adeo Health Science, a company focused on translating food allergy research into trusted products for parents. Azza was introduced to me by Daisy Robinton, also a researcher at Harvard, who was a guest on episode 23 about gene editing and explains CRISPR/Cas 9. If you haven’t heard that one yet, you can go back and grab that at digitalhealthtoday.com/23. When we recorded this episode, Azza explained that the product from the company she’s advising, Adeo Health, was just weeks away from launch. Well, they did launch the product and as this podcast goes live, I wanted to let you know that you can get it now. She explains what it is during the interview (spoiler alert - it’s a baby food that introduces 8 different allergens to infants in solid food), but I did want to let you know that the product is now available. The company name is Adeo Health and their product is called Inspired Start. Don’t worry about writing down those URLS, you can grab them and all the links we discuss in the show notes - so if you’re in the market for baby food, you can go straight to those sites and get them online. Just visit digitalhealthtoday.com/48 - and I also have the video of Rob Knight’s TEDx talk on there -that’s another thing we discuss in our conversation.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Daisy Robinton shares her thoughts about how living much longer lives, thanks to future longevity treatments, will force people to reassess how they plan their lives. -- Quantumrun.com

Daisy Robinton shares her thoughts about how whether longevity treatments will become available to the poor when approved and released to the public. Will this type of medicine worsen the divide between the rich and poor? -- Quantumrun.com

Daisy Robinton shares her thoughts about the most promising advancements in longevity research today. -- Quantumrun.com

Daisy Robinton shares her thoughts about future longevity treatments meant to stunt or reverse the aging process will involve a series of minor medical therapies that will eventually become part of your annual wellness or health maintenance regimen. -- Quantumrun.com

My guest today is Dr Daisy Robinton. I met Daisy at Wired Health in London earlier this year where she delivered a tremendous talk about CRISPR-Cas9 and once I heard it, I knew I had to ask her to come here on the program to share her insights and inspiration into the field of bioengineering. Daisy is a scientist in gene editing at Harvard University studying stem cell biology at the intersection of embryonic development and cancer. Her research focuses on molecular, cellular and developmental biology, and her papers focus on the potential and promise of stem cell research. In addition to her scientific career, she’s also an entrepreneur. Along with Dr Jack Kriendler, she cofounded Weird and Wonderful, which is a production company where they combine the arts with science to make the story of science entertaining and reach a broader audience. She was recently named one of Forbes 30 under 30 for 2017 (and just in the nick of time – she recently celebrated her 30th birthday!). She’s also a fashion and lifestyle model, promoting brands such as Reebok and Garmin, and she’s given a TedX talk (see the show notes) about the potential of gene therapy in treating aging. Daisy and I spoke about how new technologies such as CRISPR Cas-9 are accelerating the development of new genetic therapies, and how science and society are responding and adapting to the new possibilities bioengineering technologies present. I really enjoyed this conversation, and I think you will as well.  See the full show notes at http://digitalhealthtoday.com/23 Learn more about your ad choices. Visit megaphone.fm/adchoices